Research ArticleAccepted Article
IL-17A and IL-17F expression and functional responses in rheumatoid arthritis and peripheral spondyloarthritis
Sijia Chen, Iris Blijdorp, Leonieke van Mens, Rowann Bowcutt, Talia Latuhihin, Marleen van de Sande, Stevan Shaw, Nataliya Yeremenko and Dominique Baeten
The Journal of Rheumatology January 2020, jrheum.190571; DOI: https://doi.org/10.3899/jrheum.190571
Sijia Chen
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Iris Blijdorp
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Leonieke van Mens
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Rowann Bowcutt
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Talia Latuhihin
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Marleen van de Sande
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Stevan Shaw
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Nataliya Yeremenko
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Dominique Baeten
From the Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, University of Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA; New Medicines, UCB Pharma, Slough, UK. Address correspondence to Dominique Baeten, MD, PhD, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: d.l.baeten@amc.uva.nl.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
IL-17A and IL-17F expression and functional responses in rheumatoid arthritis and peripheral spondyloarthritis
Sijia Chen, Iris Blijdorp, Leonieke van Mens, Rowann Bowcutt, Talia Latuhihin, Marleen van de Sande, Stevan Shaw, Nataliya Yeremenko, Dominique Baeten
The Journal of Rheumatology Jan 2020, jrheum.190571; DOI: 10.3899/jrheum.190571
Accepted manuscript
IL-17A and IL-17F expression and functional responses in rheumatoid arthritis and peripheral spondyloarthritis
Sijia Chen, Iris Blijdorp, Leonieke van Mens, Rowann Bowcutt, Talia Latuhihin, Marleen van de Sande, Stevan Shaw, Nataliya Yeremenko, Dominique Baeten
The Journal of Rheumatology Jan 2020, jrheum.190571; DOI: 10.3899/jrheum.190571